Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

SynPhar selects class C beta-lactamase inhibitor as development candidate

Oct. 2, 1997

T-3811: a new des-F(6)-quinolone from Toyama presented at ICAAC

Oct. 2, 1997

Wakunaga develops new oral fluoroquinolones

Oct. 2, 1997

Nyotran study results described at ICAAC

Oct. 2, 1997

BioChem Therapeutic discovers new anti-HCMV agents

Oct. 2, 1997

New polyene antifungal antibiotic developed at Ajinomoto

Oct. 2, 1997

ABT-606: a new orally active diester prodrug of H2G

Oct. 1, 1997

Preclinical pharmacokinetic/efficacy data on MiKasome presented at ICAAC

Oct. 1, 1997

Xoma's XMP peptides display antifungal activity

Oct. 1, 1997

Phase I/II data on MEDI-493 presented at ICAAC

Oct. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...